Both in Biotechnology
Protara Therapeutics vs Anavex Life Sciences
Over the past year TARA returned −52.1% and AVXL returned −85.1%; their daily moves had a correlation of 0.11.
TARA −52.1% AVXL −85.1%Growth of $1, one year, split-adjusted
| Metric | TARA | AVXL |
|---|---|---|
| Price | $2.48 | $1.19 |
| Market cap | $146.6M | $110.3M |
| Today | −1.59% | −8.46% |
| 1 month | −10.1% | −37.0% |
| 6 months | −53.4% | −64.2% |
| Year to date | −53.5% | −66.6% |
| 1 year | −52.3% | −85.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $142.5M | $118.3M |
| Dividend yield | — | — |
| Volatility (60d) | 48.9% | 73.1% |
| Short % of float | 11.5% | 14.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).